| Autor: |
Pipilis, A., Andrikopoulos, G., Lekakis, J., Gotsis, A., Oikonomou, K., Toli, K., Kyrpizidis, C., Lambropoulos, S., Stefanatos, L., Goumas, G., Kochiadakis, G., Koutsogiannis, N., Kassimatis, A., Kogias, I., Kartalis, A., Kostopoulos, V., Goudevenos, J., Helios Group |
| Jazyk: |
angličtina |
| Rok vydání: |
2010 |
| Předmět: |
|
| ISSN: |
2005-2006 |
| Popis: |
INTRODUCTION: we analysed the clinical profile of patients with an ST-elevation myocardial infarction (STEMI) who arrived in hospital within 12 hrs from pain onset and either received reperfusion therapy (PCI or fibrinolytic therapy) or remained without reperfusion. METHODS: the Hellenic Infarction Observation Study (HELIOS) was a countrywide registry of acute myocardial infarction, conducted during 2005-2006. The registry enrolled 1840 patients with myocardial infarction from 31 hospitals, with a proportional representation of all types of hospitals and all geographical areas. RESULTS: of 870 patients with STEMI who were admitted within 12 hrs from pain onset, Group A received no reperfusion (n=289, 33.2%), group B underwent primary PCI (n=84, 9.7%) and group C received fibrinolysis (n=497, 57.1%). In groups A, B and C, respectively, mean age was 73 +/- 13, 61 +/- 12 and 62 +/- 13 years (p3 hrs were all independent variables related to no reperfusion therapy. CONCLUSION: reperfusion therapies are applied to relatively lower-risk patients. If a survival advantage is to be expected at the national level, more high-risk patients, such as the elderly, women, diabetics, and mainly those with advanced Killip class, should be considered for reperfusion strategies. Hellenic J Cardiol |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
